Shenyang Xingqi Pharmaceutical Co.,Ltd
SHZ: 300573.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- E. Gao
- Employees
- 2,426
- Headquarters
- Shenyang, China
- IPO year
- 2016
- Market cap
- CN¥17.3B
- Website
- https://www.sinqi.com
Loading 300573…
Loading profile data…Frequently asked questions about 300573
What does Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ) do?
Shenyang Xingqi Pharmaceutical Co., Ltd engages in the research and development, production, and sale of ophthalmic products in China. It offers corneal, anti-bacteria, artificial tears, anti-inflammation, surgical perfusate, mydriactics, anti-fatigue, and pre dry and over dry eye treatment products. The company is based in Shenyang, China.
Where does 300573.SZ trade?
Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300573.SZ in?
Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Shenyang Xingqi Pharmaceutical Co.,Ltd?
E. Gao is the chief executive officer of Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ).
Where is Shenyang Xingqi Pharmaceutical Co.,Ltd headquartered?
Shenyang Xingqi Pharmaceutical Co.,Ltd is headquartered in China.
Does 300573.SZ pay a dividend?
Yes — Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ) paid a trailing twelve-month dividend of CNY 1.41 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300573.SZ go public?
Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ) completed its initial public offering in 2016.